You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 218.7% |
| Latest | Forecast | |
|---|---|---|
| P/E | -17.1 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 0.0 | 0.0 |
| Price / Book value | -43.1 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -31.3% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | n/a | -8.63 | -9.50p | -22.9 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | n/a | -7.30 | -7.70p | -25.0 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | n/a | -8.26 | -6.40p | -21.7 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -7.41 | -4.70p | -13.4 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -7.85 | -5.40p | -7.6 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 0.00 | -9.49 | -6.11p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 0.00 | -14.66 | -7.64p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Court gives Tiziana capital reduction the nod Sharecast News | 29 Oct |
|---|---|
| Tiziana gets US patent for 'TZLS-501' antibody Sharecast News | 24 Aug |
| Tiziana gets US patent on use of 'Milciclib' Sharecast News | 21 Aug |
| Director/PDMR Shareholding | 18-Nov-20 14:00 |
|---|---|
| Phase 1b/2 Clinical Trial - Crohn's Disease | 11-Nov-20 07:05 |
| Second Price Monitoring Extn | 09-Nov-20 14:06 |
| Price Monitoring Extension | 09-Nov-20 14:01 |
| Second Price Monitoring Extn | 02-Nov-20 09:07 |